NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis

Archives of Ophthalmology

Volumn 126, Issue 4, 2008, Pages 566-570

  Dinkin, Marc J ^a   Cestari, Dean M ^b   Stein, Marion C ^b   Brass, Steve D ^b   Lessell, Simmons ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DOUBLE STRANDED DNA; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; NEUROMYELITIS OPTICA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLOR VISION DEFECT; CORNEA STROMA; CORRELATION ANALYSIS; DNA DETERMINATION; EYE FUNDUS; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LUPUS OPTIC NEUROPATHY; MYELITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC NERVE DISEASE; OPTIC NEURITIS; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADULT; AQUAPORIN 4; AUTOANTIBODIES; AUTOANTIGENS; BRAIN; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE HEMISUCCINATE; MYELITIS, TRANSVERSE; OPTIC NEURITIS; RECURRENCE;

EID: 42249085202     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.4.566     Document Type: Article

References (18)

1. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489.
2. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805-815.
3. Devic E. Myélite aigüe compliquée de névrite optique. Bull Med. 1894;8:1033-1034.
4. Beck G.Acase of diffuse myelitis associated with optic neuritis. Brain. 1927;50:687-703.
5. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114.
6. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988;38(2):180-185.
7. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112.
8. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473-477.
9. Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett. 2003;555(1):72-78.
10. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-396.
11. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566-569.
12. Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007;4(4):e133. doi: 10.1371/journal.pmed.0040133.
13. de Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002;197 (1-2):57-61.
14. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain Arch Neurol. 2006;63(7):964-968.
15. Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007;114(4):810-815.
16. Beck RW, Gal RL, Bhatti MT, et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol. 2004;137(1):77-83.
17. Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F; Spanish-Italian NMO Study Group. Revised diagnostic criteria for neuromyelitis optica (NMO): application in a series of suspected patients [published online ahead of print April 2, 2007] J Neurol. 2007;254(9):1233-1237. doi: 10.1007/s00415-007-0509-8.
18. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(pt 7):1450-1461. 571-572